Senior Director, Clinical Operations jobs in United States
cer-icon
Apply on Employer Site
company-logo

Revolution Medicines · 3 days ago

Senior Director, Clinical Operations

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Director of Clinical Operations will be responsible for the operational design and execution of early-stage clinical studies, including managing the Clinical Development Plan and overseeing clinical trials.

Health CareLife ScienceMedical
check
H1B Sponsor Likelynote

Responsibilities

The development, management, and execution of the Clinical Development Plan (CDP) for clinical programs which includes clinical trial timeline estimates, budgets, and resource requirements
Oversight over the execution of clinical trials, including CRO selection and site selection
Successful planning and deployment of Clinical Operations staff for project and non-project related tasks. Establish clear roles and responsibilities for team members and include opportunities to stretch skills and enable growth
Line management responsibilities include hiring, performance management, career development and mentorship
Participate in or lead team meetings and collaborate with other functional groups within the company (e.g., Clinical Development, DMPK, Regulatory, QA, Finance, Legal, etc.) to achieve clinical study goals regulations and International Council for Harmonization (ICH)/ GCP guideline

Qualification

Clinical operations experienceFDA Regulations knowledgeProject management experienceLeadership skillsOncology clinical trialsCRO selection experienceData management knowledgeMulti-tasking abilityTeamworkCommunication skills

Required

BS/MS Degree in a scientific discipline with a minimum of 12 years of clinical operations experience in the pharmaceutical or biotech industry
Minimum of 7 years project and line management experience
Extensive experience in leading and managing global phase 1-3 clinical trials within designated timelines, resources, and budgets
Experience in working with cooperative group studies and investigator sponsored trials, preferred
A demonstrable record of strong leadership and teamwork
Extensive experience in selection of CROs/ vendors and management of external resources
Must have a working knowledge of data management, data review and analysis, and drug safety, pharmacovigilance and other related functions as related to clinical trial conduct
Strong working knowledge of FDA Regulations, ICH Guidelines and GCPs governing the conduct of clinical trials
Thrives in a collaborative team setting and is driven by a desire to deploy innovative approaches and technologies in a high-energy environment
Excellent written and verbal communication skills
Ability to act as an excellent ambassador for Revolution Medicines in interactions with key opinion leaders, scientific advisors, corporate partners and, where necessary, investors
Demonstrated ability to multi-task, prioritize options, anticipate challenges, and execute on goals as a member of an interdisciplinary team is extremely important

Preferred

Experience in oncology clinical trials

Benefits

Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities

Company

Revolution Medicines

twittertwitter
company-logo
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

H1B Sponsorship

Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)

Funding

Current Stage
Public Company
Total Funding
$2.25B
Key Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M

Leadership Team

leader-logo
Luan Wilfong
Chief Human Resources Officer
linkedin
leader-logo
Steve Kelsey
President
linkedin
Company data provided by crunchbase